Full text is available at the source.
Immunopharmacology of senescence: targeting the senescence-associated secretory phenotype (SASP)—a mechanism-based review
Immune-related drugs targeting the harmful secretions from aging cells
AI simplified
Abstract
Cellular senescence is a natural process where cells permanently stop dividing, playing a role in cancer prevention and tissue repair.
- Senescent cells release inflammatory factors that can lead to chronic inflammation and disrupt immune function.
- The interaction between the immune system and senescent cells influences whether these cells are cleared or become harmful.
- Immunopharmacology explores how drugs can modify immune responses to target the harmful effects of senescent cells.
- Recent research highlights potential therapies aimed at removing senescent cells or altering their secretions to mitigate health issues.
- Developing therapies that target the senescence-associated secretory phenotype (SASP) may help improve health and address age-related diseases.
AI simplified